首页> 美国卫生研究院文献>Oncology Letters >Potential clinical value and putative biological function of miR-122-5p in hepatocellular carcinoma: A comprehensive study using microarray and RNA sequencing data
【2h】

Potential clinical value and putative biological function of miR-122-5p in hepatocellular carcinoma: A comprehensive study using microarray and RNA sequencing data

机译:miR-122-5p在肝细胞癌中的潜在临床价值和推测的生物学功能:使用微阵列和RNA测序数据的综合研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In order to determine the diagnostic efficacy of microRNA (miR)-122-5p and to identify the potential molecular signaling pathways underlying the function of miR-122-5p in hepatocellular carcinoma (HCC), the expression profiles of data collected from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO) and literature databases were analyzed, along with any associations between clinicopathological characteristics and the diagnostic value of miR-122-5p in HCC. The intersection of 12 online prediction databases and differentially expressed genes from TCGA and GEO were utilized in order to select the prospective target genes of miR-122-5p in HCC. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG) and protein-protein interaction network (PPI) analyses were subsequently performed based on the selected target genes. The average expression level of miR-122-5p was decreased in HCC patients compared with controls from TCGA database (P<0.001), and the downregulation of miR-122-5p was significantly associated with HCC tissues (P<0.001), tumor vascular invasion (P<0.001), metastasis (P=0.001), sex (P=0.006), virus infection status (P=0.001) and tissue (compared with serum; P<0.001) in cases from the GEO database. The pooled sensitivity and specificity for miR-122-5p to diagnose HCC were 0.60 [95% confidence interval (CI), 0.48–0.71] and 0.81 (95% CI, 0.70–0.89), respectively. The area under the curve (AUC) value was 0.76 (95% CI, 0.72–0.80), while in Meta-DiSc 1.4, the AUC was 0.76 (Q*=0.70). The pooled sensitivity and specificity were 0.60 (95% CI, 0.57–0.62) and 0.79 (95% CI, 0.76–0.81), respectively. A total of 198 overlapping genes were selected as the potential target genes of miR-122-5p, and 7 genes were defined as the hub genes from the PPI network. Cell division cycle 6 (CDC6), minichromosome maintenance complex component 4 (MCM4) and MCM8, which serve pivotal functions in the occurrence and development of HCC, were the most significant hub genes. The regulation of cell proliferation for cellular adhesion and the biosynthesis of amino acids was highlighted in the GO and KEGG pathway analyses. The downregulation of miR-122-5p in HCC demonstrated diagnostic value, worthy of further attention. Therefore, miR-122-5p may function as a tumor suppressor by modulating genome replication.
机译:为了确定miRNA(miR)-122-5p的诊断效力并鉴定潜在miRNA-122-5p功能在肝细胞癌(HCC)中的潜在分子信号传导途径,从癌症基因组收集的数据的表达谱分析了Atlas(TCGA),Gene Expression Omnibus(GEO)和文献数据库,以及临床病理特征与miR-122-5p在肝癌的诊断价值之间的任何关联。利用12个在线预测数据库和来自TCGA和GEO的差异表达基因的交集来选择HCC中miR-122-5p的预期靶基因。随后根据选定的靶基因进行了基因本体论(GO),《京都基因与基因组百科全书》(KEGG)和蛋白质-蛋白质相互作用网络(PPI)分析。与TCGA数据库中的对照相比,HCC患者中miR-122-5p的平均表达水平降低了(P <0.001),miR-122-5p的下调与肝癌组织(P <0.001),肿瘤血管明显相关GEO数据库中的病例的侵袭性(P <0.001),转移性(P = 0.001),性别(P = 0.006),病毒感染状态(P = 0.001)和组织(与血清相比; P <0.001)。 miR-122-5p诊断HCC的综合敏感性和特异性分别为0.60 [95%置信区间(CI),0.48-0.71]和0.81(95%CI,0.70-0.89)。曲线下面积(AUC)值为0.76(95%CI,0.72-0.80),而在Meta-DiSc 1.4中,AUC为0.76(Q * = 0.70)。合并的敏感性和特异性分别为0.60(95%CI,0.57-0.62)和0.79(95%CI,0.76-0.81)。总共选择了198个重叠基因作为miR-122-5p的潜在靶基因,并从PPI网络中定义了7个基因作为中枢基因。最重要的中枢基因是细胞分裂周期6(CDC6),微染色体维持复合物成分4(MCM4)和MCM8,它们在肝癌的发生和发展中起关键作用。 GO和KEGG通路分析强调了细胞增殖对细胞粘附和氨基酸生物合成的调控。肝癌中miR-122-5p的下调显示出诊断价值,值得进一步关注。因此,miR-122-5p可以通过调节基因组复制来充当肿瘤抑制因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号